tiletamine hydrochloride has been researched along with EBV Infections in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TX; Jin, YY; Tian, ZQ; Wang, LL; Wang, XF; Wang, Z; Yang, WT; Yao, CM; Zhang, H | 1 |
| Chang, FR; Chuang, DW; Hunyadi, A; Liu, ST; Tung, CP; Wu, YC | 1 |
2 other study(ies) available for tiletamine hydrochloride and EBV Infections
| Article | Year |
|---|---|
Dehydroxymethylepoxyquinomicin selectively ablates T-CAEBV cells.
Topics: Apoptosis; Base Sequence; Benzamides; Cells, Cultured; Chronic Disease; Cyclohexanones; DNA Primers; Epstein-Barr Virus Infections; Flow Cytometry; Gene Expression; Humans; NF-kappa B; Oxidative Stress; Real-Time Polymerase Chain Reaction | 2015 |
Inhibition of the Epstein-Barr virus lytic cycle by protoapigenone.
Topics: Cell Line; Cyclohexanones; Down-Regulation; Epstein-Barr Virus Infections; Ferns; Flavones; Gene Expression Regulation, Viral; Herpesvirus 4, Human; Humans; Plant Extracts; Viral Proteins | 2011 |